Evidence map›Paper›PMID 40247815›Full record

ArticleCancer medicine2025

A Scoping Review of Interventions to Address Financial Toxicity in Pediatric and Adult Patients and Survivors of Cancer.

Christina Ping, D Carolina Andrade, Ashley Housten, Michelle Doering, Eliana Goldstein, Mary C Politi

Abstract readScoping Review
In one paragraph

Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Adapting a Cancer Cost and Health Insurance Tool for Implementation: Rapid Qualitative Analysis.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  2. Observational
  3. Financial toxicity in insured cancer patients: association with global health status in a prospective Brazilian Cohort.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Observational
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christina PingWashington University School of Medicine, Saint Louis, Missouri, USA.ORCID https://orcid.org/0000-0001-9393-9583
D Carolina AndradeDepartment of Surgery, Division of Public Health Sciences, Washington University School of Medicine, Saint Louis, Missouri, USA.
Ashley HoustenDepartment of Surgery, Division of Public Health Sciences, Washington University School of Medicine, Saint Louis, Missouri, USA.ORCID https://orcid.org/0000-0002-7379-0678
Michelle DoeringBernard Becker Medical Library, Washington University School of Medicine, Saint Louis, Missouri, USA.
Eliana GoldsteinSchool of Public Health, Washington University in St. Louis, Saint Louis, Missouri, USA.
Mary C PolitiSchool of Public Health, Washington University in St. Louis, Saint Louis, Missouri, USA.ORCID https://orcid.org/0000-0001-9103-6495

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Mach-LETSGO: Machine-LEarning of Treatment, Survey, and Genetics towards Obtaining Correct Classification of Chronic Conditions in Adult Survivors in the Childhood Cancer Survivor Study - CCSS SupplU24CA055727 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Gregory Armstrong · 1999 to 2026
$96.7M
Alvin J. Siteman Cancer Center T32CA009621NCI NIH HHS P30 CA091842NCI NIH HHS U19 CA291430-5631NCI NIH HHS U24 CA055727NCI NIH HHS U24CA55727;PIArmstrongSt. Jude Children's Research Hospital-Washington University St Louis Implementation Sciences Collaborative
6 · The paper itself

Abstract

backgroundFinancial toxicity (FT) is a common and significant challenge for people with cancer, impacting immediate clinical outcomes such as treatment adherence, as well as long-term outcomes such as quality of life and mortality. Multiple studies have tested interventions to address FT and develop recommendations for their implementation.

methodsIn this scoping review, we analyzed thirty-six studies across 35,405 participants examining institution-based interventions for FT in both pediatric and adult patients and survivors of cancer in the U.S.

resultsCommon interventions included: financial navigation (n = 15), direct financial/medical assistance (n = 8), financial counseling or coaching (n = 5), and cost conversations prompters or encounter decision aids for treatment and cost (n = 5). Outcome measures varied widely, including the COmprehensive Score for financial Toxicity (COST), the Medical Expenditure Panel Survey (MEPS), total out-of-pocket costs or savings, and mental/psychological quality-of-life measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). Many interventions showed promising results on improving FT, including financial assistance (e.g., free medication, copay assistance), treatment and insurance decision aids, and financial counseling. These strategies improved FT-related metrics, including patient out-of-pocket costs, care-related financial burden, health insurance knowledge, quality of life, and even overall survival. There was no dominant intervention method, with both low- and high-resource options proving effective. DISCUSSION: Future research should seek to understand causal relationships between interventions and FT through robust study designs, such as randomized controlled trials with longitudinal follow-up, and evaluate interventions' implementation potential. There is also a need for standardized metrics for evaluating and reporting FT to better compare different interventions' success.

Indexed as

Cancer SurvivorsCost of IllnessHealth ExpendituresNeoplasmsAdultChildHumansQuality of Lifefinancial stresshealth expenditureneoplasmquality of life

Identifiers

PMID40247815
PMCPMC12006751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.